...
首页> 外文期刊>Heart failure reviews >Improvement of hyponatremia is associated with lower mortality risk in patients with acute decompensated heart failure: a meta-analysis of cohort studies
【24h】

Improvement of hyponatremia is associated with lower mortality risk in patients with acute decompensated heart failure: a meta-analysis of cohort studies

机译:低钠血症的改善与急性失代偿性心力衰竭患者的死亡风险降低:群组研究的荟萃分析

获取原文
获取原文并翻译 | 示例
           

摘要

Hyponatremia at admission is predictive of poor prognosis in patients with acute decompensated heart failure (ADHF). We performed a meta-analysis of cohort studies to evaluate whether improvement of hyponatremia is associated with improved survival in patients with ADHF and hyponatremia. Relevant studies were identified through systematic search of PubMed and Embase. A random-effect model was used to pool the results. Predefined subgroup analyses were performed to explore the source of heterogeneity. Five thousand seven hundred fourteen patients with ADHF and hyponatremia from eight cohort studies were included. Results showed that improvement of hyponatremia during hospitalization was associated with lower risk of all-cause mortality (RR=0.65, 95% CI 0.53 to 0.80, p0.001) as compared with those without improvement of hyponatremia. Results of subgroup analyses indicated that improvement of hyponatremia was associated with more remarkable changes of short-term (within 3months after discharge) mortality (RR=0.54) as compared with long-term mortality (RR=0.74). Other factors such as study design, sample size, and heart failure subtypes did not affect the association. This was further confirmed by the meta-analysis of studies with multivariate analysis, which also suggested an association between improved hyponatremia and lower risk of all-cause mortality in ADHF patients (adjusted RR=0.63, 95% CI 0.43 to 0.92, p=0.02; I-2=63%). These results suggested that improvement of hyponatremia in ADHF patients is associated with lower mortality risk during follow-up, particularly for the short-term mortality.
机译:入学的低钠血症是预测急性失代偿性心力衰竭(ADHF)的患者预后不良。我们对队列研究进行了荟萃分析,以评估低钠血症的改善是否与ADHF和低钠血症患者的生存改善有关。通过系统搜索PubMed和Embase来确定相关研究。随机效果模型用于汇集结果。进行预定义的亚组分析以探索异质性的来源。包括五千七百患有来自八个队列研究的ADHF和低钠血症患者。结果表明,与没有改善低钠血症的人相比,随着低钠血症的情况相比,随着Hyponα的情况相比,所有因果性死亡率(RR = 0.65,95%CI 0.53至0.80,P <0.001)的风险较低,肝脏血症的改善有关。亚组分析的结果表明,与长期死亡率相比(RR = 0.74)相比,低血管血症的改善与短期(放电后3个月内的3个月内)变化(RR = 0.54)相关联。其他因素,如研究设计,样本大小和心力衰竭亚型不影响该协会。通过多变量分析的研究荟萃分析进一步证实,这也提出了改善的低钠血症之间的关联,并且在ADHF患者中的所有因果死亡率降低(调节的RR = 0.63,95%CI 0.43至0.92,P = 0.02 ; I-2 = 63%)。这些结果表明,ADHF患者中低钠血症的改善与后续行动期间的死亡率较低,特别是对于短期死亡率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号